选择模板

更多 发表的帖子

167454

浏览

【成长之路】过来人的点拨: 研究生能力自我培养

回帖:759    收藏:2577    投票:208

106802

浏览

【讨论】从丁苯酞上市后的尴尬说起

回帖:64    收藏:54    投票:4

65975

浏览

【转载】在哈佛医学院做实习医师的点滴感触 ZT

回帖:408    收藏:771    投票:118

更多 最新动态

  • freelane
    freelane  回复了帖子 大学退学被病魔折磨11年, 自我发明手术 自救 治愈自己 55天前
    Still, other than doctors' visits, a high school reunion and a few weddings, Lindsay's autonomic dysfunction kept him mostly confined to the house he grew up in well beyond his twenties.Why was he so sick, he wondered? Something was dumping way too much adrenaline into his blood.Coghlan told him he might have an adrenal tumor. But three scans of hi
  • freelane
    freelane  回复了帖子 大学退学被病魔折磨11年, 自我发明手术 自救 治愈自己 55天前
    As a teenager, watching his family members sidelined from life, Lindsay wondered whether his body was a ticking time bomb, too.Finally, that day in 1999, the alarm went off."When I called my mom that night to tell her I needed to drop out (of college), we both knew," he said. The family curse had struck.He found answers in discarded medical textboo
  • freelane
    freelane  发布了新帖 大学退学被病魔折磨11年, 自我发明手术 自救 治愈自己 55天前

    This college dropout was bedridden for 11 years. Then he invented a surgery and cured himselfhttps://edition.cnn.com/2019/07/27/health/doug-lindsay-invented-surgery-trnd/index.html(CNN)Doug Lindsay was 21 and starting his senior year at Rockhurst University, a Jesuit college in Kansas City, Missouri, when his world imploded.After his first day of c

  • freelane
    freelane  回复了帖子 太阳药业跃居印度最大药企 76天前
    收购兰伯西药业之后,  太阳药业老板身价反而降低. 主要是美国这边拖了后腿. 并购和规模不见得是对企业有好处, 以色利提瓦药业也犯同样毛病
  • freelane
    freelane  发布了新帖 哈佛肿瘤研究院赢得PD1关键专利官司 84天前

    Dana-Farber Scientists Win Checkpoint Inhibitor Patent LawsuitPublished: May 20, 2019 By Alex KeownVaunted immunotherapy pioneers from the Dana-Farber Cancer Institute won a key court case that could be worth billions of dollars.Two researchers, Gordon Freeman and Clive Wood, were recognized as the co-inventors on a series of ca

  • freelane
    freelane  回复了帖子 默克 Keytruda 的专利纠纷案 84天前
    Merck settles PD-1 patent lawsuit with BMS and OnoAgrees to pay $625m settlement plus royalties on sales of Keytruda until 2026Merck & Co has agreed terms to bring a patent dispute centred on its cancer immunotherapy Keytruda to an end.The US drugmaker has agreed to pay Bristol-Myers Squibb and Ono Pharmaceutical $625m to settle the patent infr
  • freelane
    freelane  发布了新帖 默克 Keytruda 的专利纠纷案 84天前

    Anatomy of a billion dollar patent drug dispute - the Merck Keytruda patentFebruary 23 2018Keytruda, the Merck brand name for pembrolizumab, is a humanized antibody used in cancer treatment. According to Reuters, Keytruda bought in more than $1 billion in sales in the third quarter of 2017, and is expected to generate peak annual sales of

  • freelane
    freelane  回复了帖子 重组DNA的发现和发明 85天前
    In 1967, Berg stepped away from pure enzymology toward a program with broader implications for molecular genetics. He became interested in gene expression and regulation in mammalian cells, and took a sabbatical to study tumor viruses with Renato Dulbecco at the Salk Institute for Biological Studies in La Jolla, California. Kornberg was infuriated.
  • freelane
    freelane  回复了帖子 重组DNA的发现和发明 85天前
    PAUL BERGPaul Berg was born in Brooklyn in 1926, the son of immigrants, Russian Jews from a small village near Minsk. His parents had no formal schooling, but they placed a high value on education. As a youth, Berg was encouraged to achieve academically, and after reading Arrowsmith by Sinclair Lewis and The Microbe Hunters by P
  • freelane
    freelane  发布了新帖 重组DNA的发现和发明 85天前

    重组DNA的发现和发明 https://medium.com/lsf-magazine/the-invention-of-recombinant-dna-technology-e040a8a1fa22In the early 1970s, a momentous series of events in the history of science unfolded at points around the San Francisco Bay. Lines of inquiry pursued at the Stanford University School of Medicine and the University of California, San Francisco converg

  • freelane
    freelane  回复了帖子 大龄女医生的闲言闲语~~~ 85天前
    要象考大学和研究生那样努力去找自己生活的另一半, 祝楼主事业和家庭都顺利美满
  • freelane
    freelane  发布了新帖 重组人胰岛素的诞生 85天前

    The “Right Protein” to Establish Recombinant Therapeuticshttps://www.genengnews.com/insights/the-right-protein-to-establish-recombinant-therapeutics/

  • freelane
    freelane  发布了新帖 Fiercebiotech Weekly News 92天前

    CROParexel pens CluePoints collab for risk-based monitoring workby Ben Adams Jun 20, 2019 7:55amParexel is looking to bolster its clinical trial work and compliance by signing a new deal with CluePoints.TechFDA clears J&J and Grifols' blood-stopping protein sprayby Conor Hale Jun 19, 2019 12:44pmJ&J’s Ethicon unit receiv

  • freelane
    freelane  回复了帖子 过来人的点拨: 研究生能力自我培养 92天前
    Six important skills to become a succesful researcher1) Being humble and open to criticism.2) Building a social network.3) Working hard, working smart.4) Having clear goals / being organized / having a good research plan.5) Stepping out of the comfort zone.6) Having good writing skills.Conclusion.
  • freelane
    freelane  发布了新帖 您的择业: 工业界和还是学术界? 92天前

    您的择业: 工业界和还是学术界? 通常有高学历,尤其是研究生以上学历的人, 经常会问自己或别人,自己的职业生涯应该在学术界还是工业界发展为好? 这二个方向的发展究竟各有什么利弊和发展空间.时间:  通常在学术界,您的时间比较自由,基本可以说是由您自由支配.但在工业界,您的时间不是您自己可自由支配.尤其是在您处于位置比较低的级别,您的上下班,做什么事,基本由公司,部门和您的主管决定.学术界的工作强度会更大,尽管是朝九晚五,但通常是不计时间,不停地工作,相反工业界的时间,相对好控制一些,不会象学术界这么拼.但为赶某些项目进度,也许会加班加点.学术界可能更加频繁.有加班和熬夜. 因为竞争更剧烈.研究:学术研究人员,只要能申请到经费,一般都在研究自己感兴趣的课题。在工业

  • freelane
    freelane  发布了新帖 医生投资生物科技 利弊之辩 151天前

    Physicians Investing in BioTech- A Pro/ConJune 17, 2015 MST  Category: Investing  33 Comments[Editor’s Note: This guest post was submitted by Michael Fishman, MD, MBA. He started his post-graduate training as a surgery resident, where he saw the light on the other side of the curtain. In transitioning to Anesthesiology, he

  • freelane
    freelane  回复了帖子 独家 | 美癌症中心三名华人教授是违规被开除的么? by 知识分子 151天前
    关键看雇佣协议和 申请政府 资金的合约是否 要求 披露 接受 其他机构和 外国 资助。 如果 没有 , 就不许药披露, 如果有 而有意不披露, 获没得到 许可。那对政府,联邦和州政府雇员,都将有麻烦。 涉及到知识产权时, 问题 更加明显。 如果 没有 与 学校和研究机构 技术转让办 协商和 披露 外部合作, 都将视为违规甚至违法。 
  • freelane
    freelane  发布了新帖 谈谈医疗保险,医生互保和医疗责任险 207天前

    保险业务和服务涉及每个人,每个家庭, 每个机构和全社会的每个成员. 天有不测风云, 我们生老病死, 我们从事任何商业和非商业活动, 从衣食住行, 从工作, 旅行, 做法律, 教学,行医, 商贸,传媒, 和投资, 都有风险和不确定性. 天灾人祸, 交通和工伤事故, 重大疾病, 偶发事件和不幸都会发生或降临在每个人, 每个家庭和机构. 从保险的意识和实践, 我们每个人都需要有这样的安排和设计, 必须要有相应的投资来避险, 不至于因病致穷, 因事故和灾难而家破财空. . 国外保险是很通行和普遍接受的业务. 有许多精心设计的产品, 并有不同的组合和形式. 供大家选择. 这方面的知识和经验也很丰富. 相比之下, 中国的保险, 尤其是商业医疗保险, 医生责任险以及其他医疗互保, 均不发达俄普及

  • freelane
    freelane  的帖子被加了3分 340天前

    每日生物医药动态报道 2018年 10月汇编

    每日生物医药动态报道 2018年 10月汇编Public Release: 15-Oct-2018Survey shows widespread skepticism of flu shotORLANDO HEALTHThe consensus among medical pro...
  • freelane
    freelane  回复了帖子 每日生物医药动态报道 2018年 10月汇编 341天前
    Public Release: 15-Oct-2018Sea snail shells dissolve in increasingly acidified oceans, study showsUNIVERSITY OF PLYMOUTHShelled marine creatures living in increasingly acidified oceans face a fight for survival as the impacts of climate change spread, a new study suggests.JOURNALFrontiers in Marine SciencePublic Release: 15-Oct-2018More clues revea

关于我们|联系我们|版权声明|资格证书|丁香志|加盟丁香园|友情链接 丁香园旗下网站: 丁香园|丁香通| 人才|会议|药学|博客